BioMall
Brand Store/BDB Bioscience/BD HorizonTM RY610 Rat Anti-Mouse CD45R (B220)
B
GENERAL CATALOGUE

BD HorizonTM RY610 Rat Anti-Mouse CD45R (B220)

571343 · 25 ug

BDB Bioscience · Cat: 571343

₹110 – ₹160 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 571343
Category: reagents
Pack Size: 25 ug
Brand: BDB Bioscience

Description

Multicolor flow cytometric analysis of CD45R B220 expression on viable Mouse splenic leukocytes. BALB/c Mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block Cat. No. 553142 and BD Pharmingen Purified Armenian Hamster Anti-Mouse FcgammaRIV CD16-2 Cat. No. 567208 antibodies. The cells were then stained with APC Hamster Anti-Mouse CD3e antibody Cat. No. 553066 and with either BD Horizon RY610 Rat IgG2a, kappa Isotype Control Cat. No. 571152; Left Plot or BD Horizon RY610 Rat Anti-Mouse CD45R B220 antibody Cat. No. 571283/571343; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD45R B220 or Ig Isotype control staining versus CD3e was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multicolor flow cytometric analysis of CD45R B220 expression on viable Mouse splenic leukocytes. BALB/c Mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block Cat. No. 553142 and BD Pharmingen Purified Armenian Hamster Anti-Mouse FcgammaRIV CD16-2 Cat. No. 567208 antibodies. The cells were then stained with APC Hamster Anti-Mouse CD3e antibody Cat. No. 553066 and with either BD Horizon RY610 Rat IgG2a, kappa Isotype Control Cat. No. 571152; Left Plot or BD Horizon RY610 Rat Anti-Mouse CD45R B220 antibody Cat. No. 571283/571343; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD45R B220 or Ig Isotype control staining versus CD3e was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multicolor flow cytometric analysis of CD45R B220 expression on viable Mouse splenic leukocytes. BALB/c Mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block Cat. No. 553142 and BD Pharmingen Purified Armenian Hamster Anti-Mouse FcgammaRIV CD16-2 Cat. No. 567208 antibodies. The cells were then stained with APC Hamster Anti-Mouse CD3e antibody Cat. No. 553066 and with either BD Horizon RY610 Rat IgG2a, kappa Isotype Control Cat. No. 571152; Left Plot or BD Horizon RY610 Rat Anti-Mouse CD45R B220 antibody Cat. No. 571283/571343; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD45R B220 or Ig Isotype control staining versus CD3e was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Multicolor flow cytometric analysis of CD45R B220 expression on viable Mouse splenic leukocytes. BALB/c Mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block Cat. No. 553142 and BD Pharmingen Purified Armenian Hamster Anti-Mouse FcgammaRIV CD16-2 Cat. No. 567208 antibodies. The cells were then stained with APC Hamster Anti-Mouse CD3e antibody Cat. No. 553066 and with either BD Horizon RY610 Rat IgG2a, kappa Isotype Control Cat. No. 571152; Left Plot or BD Horizon RY610 Rat Anti-Mouse CD45R B220 antibody Cat. No. 571283/571343; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD45R B220 or Ig Isotype control staining versus CD3e was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Multicolor flow cytometric analysis of CD45R B220 expression on viable Mouse splenic leukocytes. BALB/c Mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block Cat. No. 553142 and BD Pharmingen Purified Armenian Hamster Anti-Mouse FcgammaRIV CD16-2 Cat. No. 567208 antibodies. The cells were then stained with APC Hamster Anti-Mouse CD3e antibody Cat. No. 553066 and with either BD Horizon RY610 Rat IgG2a, kappa Isotype Control Cat. No. 571152; Left Plot or BD Horizon RY610 Rat Anti-Mouse CD45R B220 antibody Cat. No. 571283/571343; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD45R B220 or Ig Isotype control staining versus CD3e was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multicolor flow cytometric analysis of CD45R B220 expression on viable Mouse splenic leukocytes. BALB/c Mouse splenic leucocytes were preincubated with Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block Cat. No. 553142 and BD Pharmingen Purified Armenian Hamster Anti-Mouse FcgammaRIV CD16-2 Cat. No. 567208 antibodies. The cells were then stained with APC Hamster Anti-Mouse CD3e antibody Cat. No. 553066 and with either BD Horizon RY610 Rat IgG2a, kappa Isotype Control Cat. No. 571152; Left Plot or BD Horizon RY610 Rat Anti-Mouse CD45R B220 antibody Cat. No. 571283/571343; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of CD45R B220 or Ig Isotype control staining versus CD3e was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
B
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
B
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents